AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC), a clinical-stage biotech developing rapid-acting mental health treatments, announced that CEO Srinivas Rao, M.D., Ph.D., and VP of Investor Relations Jason Awe, Ph.D., will participate in fireside chats and one-on-one meetings at March investor conferences: TD Cowen (Mar 4, Boston), Jefferies Biotech on the Beach (Mar 10, Miami), and Leerink Global Healthcare (Mar 11, Miami).
Fireside chats will be webcast live and archived for 30 days on the company website.